ICD 9 Range DISEASES OF THE BLOOD AND BLOOD-FORMING ORGANS

• 1  Iron deficiency anemias     ( 280 )

• 2  Iron deficiency anemia secondary to blood loss (chronic)     ( 280.0 )

• 3  Iron deficiency anemia secondary to inadequate dietary iron intake     ( 280.1 )

• 4  Other specified iron deficiency anemias     ( 280.8 )

• 5  Iron deficiency anemia unspecified     ( 280.9 )

• 6  Other deficiency anemias     ( 281 )

• 7  Pernicious anemia     ( 281.0 )

• 8   Other vitamin B12 deficiency anemia     ( 281.1 )

• 9  Folate-deficiency anemia     ( 281.2 )

• 10  Other specified megaloblastic anemias not elsewhere classified     ( 281.3 )

• 11  Protein-deficiency anemia     ( 281.4 )

• 12  Anemia associated with other specified nutritional deficiency     ( 281.8 )

• 13  Unspecified deficiency anemia     ( 281.9 )

• 14  Hereditary hemolytic anemias     ( 282 )

• 15  Hereditary spherocytosis     ( 282.0 )

• 16  Hereditary elliptocytosis     ( 282.1 )

• 17  Anemias due to disorders of glutathione metabolism     ( 282.2 )

• 18  Other hemolytic anemias due to enzyme deficiency     ( 282.3 )

• 19  Thalassemias     ( 282.4 )

• 20  Sickle-cell thalassemia without crisis     ( 282.41 )

• 21  Sickle-cell thalassemia with crisis     ( 282.42 )

• 22  Other thalassemia     ( 282.49 )

• 23  Sickle-cell trait     ( 282.5 )

• 24  Sickle-cell disease     ( 282.6 )

• 25  Sickle-cell disease unspecified     ( 282.60 )

• 26   Hb-SS disease without crisis     ( 282.61 )

• 27   Hb-SS disease with crisis     ( 282.62 )

• 28   Sickle-cell/Hb-C disease without crisis     ( 282.63 )

• 29   Sickle-cell/Hb-C disease with crisis     ( 282.64 )

• 30  Other sickle-cell disease without crisis     ( 282.68 )

• 31  Other sickle-cell disease with crisis     ( 282.69 )

• 32  Other hemoglobinopathies     ( 282.7 )

• 33  Other specified hereditary hemolytic anemias     ( 282.8 )

• 34  Hereditary hemolytic anemia unspecified     ( 282.9 )

• 35  Acquired hemolytic anemias     ( 283 )

• 36  Autoimmune hemolytic anemias     ( 283.0 )

• 37  Non-autoimmune hemolytic anemias     ( 283.1 )

• 38  Non-autoimmune hemolytic anemia unspecified     ( 283.10 )

• 39  Hemolytic-uremic syndrome     ( 283.11 )

• 40  Other non-autoimmune hemolytic anemias     ( 283.19 )

• 41  Hemoglobinuria due to hemolysis from external causes     ( 283.2 )

• 42  Acquired hemolytic anemia unspecified     ( 283.9 )

• 43  Aplastic anemia     ( 284 )

• 44  Constitutional aplastic anemia     ( 284.0 )

• 45  Constitutional red blood cell aplasia     ( 284.01 )

• 46  Other constitutional aplastic anemia     ( 284.09 )

• 47  Pancytopenia     ( 284.1 )

• 48  Myelophthisis     ( 284.2 )

• 49  Other specified aplastic anemias     ( 284.8 )

• 50  Red cell aplasia (acquired) (adult) (with thymoma)     ( 284.81 )

• 51  Other specified aplastic anemias     ( 284.89 )

• 52  Aplastic anemia unspecified     ( 284.9 )

• 53  Other and unspecified anemias     ( 285 )

• 54  Sideroblastic anemia     ( 285.0 )

• 55  Acute posthemorrhagic anemia     ( 285.1 )

• 56  Anemia in chronic illness     ( 285.2 )

• 57  Anemia in chronic kidney disease     ( 285.21 )

• 58  Anemia in neoplastic disease     ( 285.22 )

• 59  Anemia of other chronic disease     ( 285.29 )

• 60  Other specified anemias     ( 285.8 )

• 61  Anemia unspecified     ( 285.9 )

• 62  Antineoplastic chemotherapy induced anemia     ( 285.3 )

• 63  Coagulation defects     ( 286 )

• 64   Congenital factor VIII disorder     ( 286.0 )

• 65   Congenital factor IX disorder     ( 286.1 )

• 66   Congenital factor XI deficiency     ( 286.2 )

• 67  Congenital deficiency of other clotting factors     ( 286.3 )

• 68  Von willebrand's disease     ( 286.4 )

• 69  Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors     ( 286.5 )

• 70  Defibrination syndrome     ( 286.6 )

• 71  Acquired coagulation factor deficiency     ( 286.7 )

• 72  Other and unspecified coagulation defects     ( 286.9 )

• 73  Purpura and other hemorrhagic conditions     ( 287 )

• 74  Allergic purpura     ( 287.0 )

• 75  Qualitative platelet defects     ( 287.1 )

• 76  Other nonthrombocytopenic purpuras     ( 287.2 )

• 77  Primary thrombocytopenia     ( 287.3 )

• 78  Primary thrombocytopenia,unspecified     ( 287.30 )

• 79  Immune thrombocytopenic purpura     ( 287.31 )

• 80  Evans     ( 287.32 )

• 81  Congenital and hereditary thrombocytopenic purpura     ( 287.33 )

• 82  Other primary thrombocytopenia     ( 287.39 )

• 83  Secondary thrombocytopenia     ( 287.4 )

• 84  Thrombocytopenia unspecified     ( 287.5 )

• 85  Other specified hemorrhagic conditions     ( 287.8 )

• 86  Unspecified hemorrhagic conditions     ( 287.9 )

• 87  Diseases of white blood cells     ( 288 )

• 88  Agranulocytosis     ( 288.0 )

• 89  Neutropenia, unspecified     ( 288.00 )

• 90  Congenital neutropenia     ( 288.01 )

• 91  Cyclic neutropenia     ( 288.02 )

• 92  Drug induced neutropenia     ( 288.03 )

• 93  Neutropenia due to infection     ( 288.04 )

• 94  Other neutropenia     ( 288.09 )

• 95  Functional disorders of polymorphonuclear neutrophils     ( 288.1 )

• 96  Genetic anomalies of leukocytes     ( 288.2 )

• 97  Eosinophilia     ( 288.3 )

• 98  Hemophagocytic syndromes     ( 288.4 )

• 99  Decreased white blood cell count     ( 288.5 )

• 100  Leukocytopenia, unspecified     ( 288.50 )

• 101  Lymphocytopenia     ( 288.51 )

• 102  Other decreased white blood cell count     ( 288.59 )

• 103  Elevated white blood cell count     ( 288.6 )

• 104  Leukocytosis, unspecified     ( 288.60 )

• 105  Lymphocytosis (symptomatic)     ( 288.61 )

• 106  Leukemoid reaction     ( 288.62 )

• 107  Monocytosis (symptomatic)     ( 288.63 )

• 108  Plasmacytosis     ( 288.64 )

• 109  Basophilia     ( 288.65 )

• 110  Bandemia     ( 288.66 )

• 111  Other elevated white blood cell count     ( 288.69 )

• 112  Other specified disease of white blood cells     ( 288.8 )

• 113  Unspecified disease of white blood cells     ( 288.9 )

• 114  Other diseases of blood and blood-forming organs     ( 289 )

• 115  Polycythemia secondary     ( 289.0 )

• 116  Chronic lymphadenitis     ( 289.1 )

• 117  Nonspecific mesenteric lymphadenitis     ( 289.2 )

• 118  Lymphadenitis unspecified except mesenteric     ( 289.3 )

• 119  Hypersplenism     ( 289.4 )

• 120  Other diseases of spleen     ( 289.5 )

• 121  Disease of spleen unspecified     ( 289.50 )

• 122  Chronic congestive splenomegaly     ( 289.51 )

• 123  Splenic sequestration     ( 289.52 )

• 124  Neutropenic splenomegaly     ( 289.53 )

• 125  Other diseases of spleen     ( 289.59 )

• 126  Familial polycythemia     ( 289.6 )

• 127  Methemoglobinemia     ( 289.7 )

• 128  Other specified diseases of blood and blood-forming organs     ( 289.8 )

• 129  Primary hypercoagulable state     ( 289.81 )

• 130  Secondary hypercoagulable state     ( 289.82 )

• 131  Myelofibrosis     ( 289.83 )

• 132   Heparin-induced thrombocytopenia (HIT)     ( 289.84 )

• 133  Other specified diseases of blood and blood-forming organs     ( 289.89 )

• 134  Unspecified diseases of blood and blood-forming organs     ( 289.9 )

• 135  Posttransfusion purpura     ( 287.41 )

• 136  Other secondary thrombocytopenia     ( 287.49 )

• 137  Thalassemia, unspecified     ( 282.40 )

• 138  Alpha thalassemia     ( 282.43 )

• 139  Beta thalassemia     ( 282.44 )

• 140  Delta-beta thalassemia     ( 282.45 )

• 141  Thalassemia minor     ( 282.46 )

• 142  Hemoglobin E-beta thalassemia     ( 282.47 )

• 143  Antineoplastic chemotherapy induced pancytopenia     ( 284.11 )

• 144  Other drug-induced pancytopenia     ( 284.12 )

• 145  Other pancytopenia     ( 284.19 )

• 146  Acquired hemophilia     ( 286.52 )

• 147  Antiphospholipid antibody with hemorrhagic disorder     ( 286.53 )

• 148  Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors     ( 286.59 )